Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Marmara Pharmaceutical Journal
2017 , Vol 21 , Issue 1
Aterosklerozun Patofizyolojisi ve Risk Faktörleri
1Marmara Üniversitesi, Eczacılık Fakültesi, Biyokimya Anabilim Dalı, Haydarpaşa, 34668/İstanbul,Türkiye
DOI :
10.12991/marupj.259875
Atherosclerosis and its complications is the leading cause of
death both in our country and in the world. Atherosclerosis is a
disease that affects the intima layers of medium and large arteries
with its typical lesions "atherosclerotic plaques". Endothelial
dysfunction is one of the basic mechanisms in the atherosclerotic
process. Classic and newly identified risk factors leading to a
decrease in the vasodilator response creates chronic injury. Thus,
vasoconstriction composed in endothelium, accumulation of
inflammatory cells, smooth muscle cell migration, cytokine
production cause the increase of events such as the formation
of atherosclerotic plaques. Endothelial dysfunction is not only the first step of the atherosclerotic plaque formation process,
but also cause triggering of atherogenic events cracking and the
growth of plaque. The most important factor that plays a role
in the pathogenesis of atherosclerosis is hypercholesterolemia.
Epidemiological studies indicate that along many genetic and
environmental factors, increased serum cholesterol levels is
enough alone for development of atherosclerosis in the absence
of other known risk factors. In this study, lipoproteins that
are considered to contribute formation of the pathogenesis of
atherosclerosis by creating foam cells were examined and it
is aimed to evaluate this phenomenon considering the many
parameters joining it.
Keywords :
Atherosclerosis, risk factors, pathophysiology of atherosclerosis